COCRYSTAL PHARMA, INC. Operating Lease Liability
COCRYSTAL PHARMA, INC. (COCP) had Operating Lease Liability of $1.34 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $1.34M.
- 2026-03-31: Operating Lease, Liability $1.42M.
- 2025-12-31: Operating Lease, Liability $1.50M.
- 2025-09-30: Operating Lease, Liability $1.58M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.42M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.50M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.58M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.66M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.73M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.81M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.88M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.78M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.82M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.85M 10-K · filed 2025-03-31 |
| 2023-09-30 | $118.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $176.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $234.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $290.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $346.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $398.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $449.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $500.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $548.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $426.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $476.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $523.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $569.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $613.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $657.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $700.00K 10-K · filed 2021-03-17 |
| 2019-09-30 | $740.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $780.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $818.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |